carbidopa and benserazide

carbidopa has been researched along with benserazide in 142 studies

Research

Studies (142)

TimeframeStudies, this research(%)All Research%
pre-199099 (69.72)18.7374
1990's16 (11.27)18.2507
2000's10 (7.04)29.6817
2010's15 (10.56)24.3611
2020's2 (1.41)2.80

Authors

AuthorsStudies
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Agnoli, A; Carolei, A; Casacchia, M; Fazio, C; Zamponi, A1
Rinne, UK1
Coxon, A; Greenacre, JK; Petrie, A; Reid, JL1
Darwish, SA; Furman, BL1
Boggan, WO; Buckholtz, NS; Meyer, JS1
Dollery, CT; Kersting, F; Reid, JL2
Appel, JB; Carter, RB; Dykstra, LA; Leander, JD1
Hjälmås, K; Rubenson, A; Sillén, U1
Battistin, L; Meneghetti, G; Rigotti, S; Saia, A1
Diamond, SG; Markham, CH; Treciokas, LJ1
van Rossum, JM1
Del Pesce, M; Di Bella, P; Forastieri, L; Paggi, A; Quattrini, A1
Chia, YC; Lees, GJ; Waterhouse, MJ1
Birkmayer, W; Mentasti, M; Podiwinsky, F; Riederer, P1
Bender, DA; Earl, CJ; Lees, AJ1
Carolei, A; Masturzo, P; Murialdo, G; Polleri, A2
Fernstrom, JD; Wiggins, JF1
Estey, E; Goldstein, M; Gopinathan, G; Lieberman, A; Ohashi, T; Sauter, A1
Mölsä, P; Rinne, UK1
Feuerstein, C; Gavend, M; Pellat, J; Perret, J; Serre, F; Tanche, M2
Dessi'-Fulgheri, P; Glorioso, N; Monaco, F; Rappelli, A; Tedde, R1
Kuzuya, F; Mori, K; Sakamoto, N; Yoshimine, N1
Clemens, R1
Avery, GS; Brogden, RN; Pinder, RM; Sawyer, PR; Speight, TM1
Bissessur, S; De Man, JJ; Lakke, JP; Moll, L; Seegers, J; Wesseling, H; Witt, FG1
Carolei, A; Casacchi, M; Fazio, C1
Messiha, FS1
David, JC1
Goodwin, BL; Johnson, RD; Ruthven, CR; Sandler, M1
Goodale, DB; Moore, KE1
Mizuno, Y; Obayashi, T; Ueki, A; Yoshida, M1
Cooper, RL; Linnoila, M1
Gabreëls, FJ; Joosten, EM; Keyser, A; Korten, JJ1
Barbeau, A1
Bartholini, J; Constantinidis, J; Pletscher, A; Puig, M; Tissot, R1
Maj, J; Przewlocka, B1
Antonaccio, MJ; Kerwin, L1
Birket-Smith, E; Dupont, E; Hansen, E; Mikkelsen, B; Pakkenberg, H; Presthus, J; Rautakorpi, I; Riman, E; Rinne, UK1
Bramante, L; Quinn, NP; Ruggieri, S; Steiger, MJ; Stocchi, F1
Furukawa, Y; Kondo, T; Mizuno, Y; Narabayashi, H; Nishi, K1
Kleedorfer, B; Poewe, W1
Baruzzi, A; Contin, M; Martinelli, P; Riva, R1
Ashwood, TJ; Bateman, DN; Tulloch, JA; Woodhouse, KW1
Berger, HJ; Horstink, MW; Pasman, JW; van't Hof, MA; Zijlmans, JC1
Rinne, JO; Rinne, UK1
Ingvarsson, PE; Johnels, B; Steg, G; Thorselius, M; Valls, M1
Emskötter, T; Heidenreich, C; Lachenmayer, L1
Koller, WC; Lang, AE; Marsden, CD; Quinn, NP1
Kato, T; Katsube, J; Katsuyama, M; Maeda, Y; Nakamura, M; Nishikawa, S1
Birkmayer, W1
Lindström, P; Ohlsson, L1
Birkmayer, JD; Birkmayer, W1
Da Prada, M; Haefely, WE; Kettler, R; Schaffner, R; Zürcher, G1
Lieberman, AN1
Wilson, JA1
Langdon, N; Malcolm, PN; Parkes, JD1
Kapfhammer, HP; Kuss, HJ; Rüther, E1
Caraceni, T; Giovannini, P; Grassi, MP; Piccolo, I; Scigliano, G; Soliveri, P1
Berglund, B; Kaijser, L; Sachs, C1
Azevedo, M; Coelho, H; Manso, C1
Admani, AK; Cordingley, GJ; Harris, RI; Verma, S1
Kawai, K; Kitamura, J; Mori, H; Sugie, S1
Zhou, XD1
Yu, HZ1
Clark, WG; Dewherst, WG; Oldendorf, WH1
Minsker, DH; Stokes, AL1
Rondot, P1
Antonaccio, MJ; Burrell, R; Robson, RD1
Friedman, E; Gershon, S1
Paparo, AA; Tate, SS1
Henning, M; Johansson, P2
Casey, DE; Gerlach, J1
Dean, RC; Murphy, JA; Paparo, AA1
Magnussen, I; Van Woert, MH1
Bodhankar, S; Osuide, G; Wambebe, C1
Ganong, WF; Kaplan, SL; Zimmermann, H1
Gerstenbrand, F; Poewe, W; Ransmayr, G1
Da Prada, M; Haefely, WE; Keller, HH; Kettler, R; Pieri, L1
Bender, DA2
Goldstein, M; Gopinathan, G; Hiesiger, E; Lieberman, AN; Nelson, J; Neophytides, A; Walker, R1
Rondot, P; Ziegler, M1
Gerdes, U; Lehmann, K; Ulm, G1
Kamenetskiĭ, VK1
Agnoli, A; Baldassarre, M; D'Urso, R; Del Roscio, S; Falaschi, P; Frajese, G; Mearelli, S; Rocco, A; Ruggieri, S1
Alaghband-Zadeh, J; Das, PK; Gawel, MJ; Lavin, PJ; Rose, FC1
Anderson, GM; Chouinard, G; Gauthier, S; Purdy, WC; Young, SN1
Caraceni, T; Cocchi, D; Giovannini, P; Martinez-Campos, A; Müller, EE; Novelli, A1
Juorio, AV1
Carter, RB; Leander, JD1
Barney, CC; Fregly, MJ; Greenleaf, JE; Kikta, DC; Threatte, RM1
Ganong, WF; Zimmermann, H1
Agnoli, A; Baldassarre, M; D'Urso, R; De Giorgio, G; Falaschi, P; Rocco, A; Ruggieri, S1
Keren, O; Korczyn, AD1
Hildick-Smith, M1
Johansson, P1
Agnoli, A; Bruno, G; Denaro, A; Ruggieri, S1
de Vries, T; Garbis-Berkvens, JM; Peters, PW; Rauws, AG; van Logten, MJ; Vos, JG1
Giorgi, O; Rubio, MC1
Pogson, CI; Smith, SA1
Gulliver, PA; Hagan, RM; Raxworthy, MJ1
Boomsma, F; Man in 't Veld, A; Schalekamp, M; van den Meiracker, A1
Atchison, PR; Frackowiak, RS; Marsden, CD; Thompson, PD1
Imai, H; Kondo, T; Nakamura, T; Narabayashi, H1
Da Prada, M; Dingemanse, J; Zürcher, G1
Linazasoro, G; Martí Massó, JF; Suárez, JA1
Bowes, SG; Charlett, A; Dobbs, RJ; Dobbs, SM; Nicholson, PW; O'Neill, CJ; Purkiss, A; Weller, C1
Amiel, C; Comoy, E; Couette, S; Friedlander, G; Garcia-Ocaña, A; Perrichot, R1
Ichikawa, M; Matsuyama, K; Nakashima, M; Nakashima, MN; Sakurai, M; Sasaki, H; Zhao, MF1
Barbato, L; Berardelli, A; Bonamartini, A; Manfredi, M; Patsalos, PN; Ruggieri, S; Stocchi, F1
Goetz, CG1
Banken, L; Fotteler, B; Jorga, K; Snell, P; Steimer, JL1
Bennett, KM; Bonfiglioli, C; Castiello, U; Peppard, RF1
Fanali, S; Pucci, V; Raggi, MA; Sabbioni, C1
Ebinger, G; Jonkers, N; Michotte, Y; Sarre, S1
Borri-Voltattorni, C; Burkhard, P; Dominici, P; Jansonius, JN; Malashkevich, VN1
Hironishi, M; Kondo, T; Miwa, H1
Fekete, MI; Fülöp, F; Homicskó, KG; Kertész, I; Nagy, GM; Radnai, B; Tóth, BE; Tóth, G1
Fung, VS; Herawati, L; Wan, Y1
Cannas, A; Floris, G; Marrosu, F; Marrosu, MG; Piga, M; Serra, A; Solla, P; Tacconi, P1
García-Cánovas, F; Garcia-Molina, F; Garcia-Molina, M; Munoz-Munoz, JL; Rodriguez-Lopez, JN; Tudela, J1
Amar, K; Eggert, K; Kuoppamäki, M; Leinonen, M; Luotonen, L; Nissinen, H; Oertel, W; Skogar, O1
Adamiak, U; Bialecka, M; Gawronska-Szklarz, B; Kaldonska, M; Klodowska-Duda, G; Safranow, K; Wyska, E1
Fisher, R; Jackson, MJ; Jenner, P; Rose, S; Tayarani-Binazir, KA; Zoubiane, G1
Eggert, K; Eichhorn, T; Oertel, WH; Ries, V; Selzer, R1
Almeida, L; Ferreira, JJ; Nunes, T; Poewe, W; Rascol, O; Rocha, JF; Sampaio, C; Soares-da-Silva, P1
Alvarez-Lueje, A; Bravo, M; Olivieri, AC; Pérez-Ortiz, M; Zapata-Urzúa, C1
Adam, JJ; Duits, A; Scholtissen, B; van Houdt, H; Visser-Vandewalle, V; Winogrodzka, A1
Ishihara, A; Kihira, K; Kimura, Y; Matsumoto, M; Miyachi, T; Nakamura, T; Ohtsuki, T; Yamawaki, T1
Grandas, FJ; Sesar-Ignacio, Á1
Falcão, A; Ferreira, JJ; Nunes, T; Pinto, R; Rocha, JF; Santos, A; Soares-da-Silva, P1
Kuoppamäki, M; Leinonen, M; Poewe, W1
Almeida, L; Falcão, A; Ferreira, JJ; Nunes, T; Pinto, R; Rocha, JF; Santos, A; Soares-da-Silva, P1
Almeida, L; Bonifácio, MJ; Falcão, A; Fauchoux, N; Loureiro, AI; Nunes, T; Pinto, R; Rocha, JF; Santos, A; Sicard, É; Soares-da-Silva, P1
Klein, S; Wollmer, E1
Babu, S; Chang, FC; Dal, S; Fletcher, N; Fung, VSC; Mahant, N; Martin, AJ; Morales-Briceno, H; Nankervis, J; Ong, TL; Robbie, M; Williams, LJ1
Baba, Y; Futamura, A; Kinno, R; Nabeshima, Y; Nomoto, S; Osakabe, Y; Shoji, D; Takahashi, S; Yasumoto, T1

Reviews

6 review(s) available for carbidopa and benserazide

ArticleYear
Recent advances in research on Parkinsonism.
    Acta neurologica Scandinavica. Supplementum, 1978, Volume: 67

    Topics: Acetylcholinesterase; Adult; Apomorphine; Benserazide; Brain; Bromocriptine; Carbidopa; Dopa Decarboxylase; Dopamine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Norepinephrine; Parkinson Disease; Selegiline; Serotonin; Substance P; Tyrosine 3-Monooxygenase

1978
Two types of dopamine receptors in behavioral regulation.
    Federation proceedings, 1978, Volume: 37, Issue:10

    Topics: Animals; Behavior; Behavior, Animal; Benserazide; Brain; Carbidopa; Cats; Dopamine; Haloperidol; Humans; Levodopa; Psychomotor Agitation; Rats; Receptors, Dopamine; Reserpine; Snails; Tranquilizing Agents

1978
Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.
    Drugs, 1976, Volume: 11, Issue:5

    Topics: Benserazide; Binding Sites; Carbidopa; Carboxy-Lyases; Drug Interactions; Humans; Hydrazines; Kinetics; Levodopa; Liver Function Tests; Parkinson Disease

1976
The pharmacology of Parkinson's disease: basic aspects and recent advances.
    Experientia, 1984, Nov-15, Volume: 40, Issue:11

    Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Bromocriptine; Carbidopa; Corpus Striatum; Dopamine; Ergolines; Humans; Kidney; Kinetics; Levodopa; Lisuride; Liver; Methyldopa; Norepinephrine; Parkinson Disease; Pergolide; Receptors, Dopamine; Selegiline; Serotonin; Stereotyped Behavior; Substantia Nigra; Tyramine

1984
The syndrome of gait ignition failure: a report of six cases.
    Movement disorders : official journal of the Movement Disorder Society, 1993, Volume: 8, Issue:3

    Topics: Aged; Benserazide; Brain; Carbidopa; Diagnosis, Differential; Drug Therapy, Combination; Female; Gait; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Neurologic Examination; Parkinson Disease; Syndrome; Tomography, X-Ray Computed

1993
[Subcutaneous continuous apomorphine infusion: treatment initiation and follow up].
    Revista de neurologia, 2012, Volume: 55 Suppl 1

    Topics: Aftercare; Ambulatory Care; Antiparkinson Agents; Apomorphine; Benserazide; Carbidopa; Caregivers; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Infusions, Subcutaneous; Levodopa; Parkinson Disease; Patient Education as Topic; Patient Selection; Retrospective Studies

2012

Trials

24 trial(s) available for carbidopa and benserazide

ArticleYear
Comparison of levodopa with carbidopa or benserazide in parkinsonism.
    Lancet (London, England), 1976, Aug-21, Volume: 2, Issue:7982

    Topics: Aged; Benserazide; Carbidopa; Consumer Behavior; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease

1976
Clinical and cardiovascular effects of alpha methyldopa in combination with decarboxylase inhibitors.
    Clinical pharmacology and therapeutics, 1977, Volume: 21, Issue:5

    Topics: Adult; Benserazide; Blood Pressure; Carbidopa; Carboxy-Lyases; Clinical Trials as Topic; Cold Temperature; Drug Interactions; Drug Therapy, Combination; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Hypnotics and Sedatives; Male; Methyldopa; Middle Aged; Salivation; Valsalva Maneuver

1977
Long-term treatment of Parkinson's disease with L-Dopa and Dopa-decarboxylase inhibitor: therapeutic results and side effects.
    Acta neurologica Scandinavica, 1978, Volume: 57, Issue:2

    Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors

1978
A double-blind comparison of levodopa, Madopa, and Sinemet in Parkinson disease.
    Annals of neurology, 1978, Volume: 3, Issue:3

    Topics: Adult; Benserazide; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Vomiting

1978
[Efficacy and side-effects of long term L-dopa therapy in Parkinsonian syndromes (evaluated by CT scan as well) (author's transl)].
    Rivista di patologia nervosa e mentale, 1979, Volume: 99, Issue:5

    Topics: Adult; Benserazide; Brain; Carbidopa; Clinical Trials as Topic; Confusion; Electrocardiography; Electroencephalography; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Stomach Diseases; Tomography, X-Ray Computed

1979
[The combined treatment of Parkinson's disease with L-dopa plus decarboxylase inhibitors (carbidopa, benserazide) (author's transl)].
    Wiener klinische Wochenschrift, 1979, May-11, Volume: 91, Issue:10

    Topics: Aged; Benserazide; Carbidopa; Drug Combinations; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease

1979
Levodopa with benserazide or carbidopa in Parkinson disease.
    Neurology, 1979, Volume: 29, Issue:12

    Topics: Benserazide; Biological Availability; Carbidopa; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease

1979
[Sinomet and Madopar, a comparative study on the treatment of Parkinson's disease].
    Nederlands tijdschrift voor geneeskunde, 1976, Oct-02, Volume: 120, Issue:40

    Topics: Benserazide; Carbidopa; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Humans; Levodopa; Parkinson Disease

1976
Madopar versus sinemet. A clinical study on their effectiveness.
    European neurology, 1975, Volume: 13, Issue:2

    Topics: Adult; Aged; Benserazide; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Serine

1975
Parkinson's disease treated with Sinemet or Madopar. A controlled multicenter trial.
    Acta neurologica Scandinavica, 1976, Volume: 53, Issue:5

    Topics: Aged; Benserazide; Carbidopa; Drug Combinations; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease

1976
Comparative efficacy of two oral sustained-release preparations of L-dopa in fluctuating Parkinson's disease. Preliminary findings in 20 patients.
    Journal of neural transmission. Parkinson's disease and dementia section, 1992, Volume: 4, Issue:2

    Topics: Benserazide; Carbidopa; Delayed-Action Preparations; Drug Combinations; Follow-Up Studies; Humans; Levodopa; Parkinson Disease

1992
A single-dose study of the pharmacodynamic effects of chlormethiazole, temazepam and placebo in elderly parkinsonian patients.
    Age and ageing, 1991, Volume: 20, Issue:6

    Topics: Aged; Benserazide; Carbidopa; Chlormethiazole; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Sleep Initiation and Maintenance Disorders; Sleep Stages; Temazepam

1991
Patient benefits of l-dopa and a decarboxylase inhibitor in the treatment of Parkinson's disease in elderly patients.
    Pharmatherapeutica, 1985, Volume: 4, Issue:2

    Topics: Activities of Daily Living; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Carbidopa; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1985
Defining small differences in efficacy between anti-parkinsonian agents using gait analysis: a comparison of two controlled release formulations of levodopa/decarboxylase inhibitor.
    British journal of clinical pharmacology, 1993, Volume: 35, Issue:4

    Topics: Aged; Analysis of Variance; Antiparkinson Agents; Benserazide; Carbidopa; Carboxy-Lyases; Delayed-Action Preparations; Drug Combinations; Female; Gait; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1993
Population pharmacokinetics of tolcapone in parkinsonian patients in dose finding studies.
    British journal of clinical pharmacology, 2000, Volume: 49, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antiparkinson Agents; Area Under Curve; Benserazide; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Enzyme Inhibitors; Female; Humans; Levodopa; Male; Middle Aged; Models, Statistical; Nitrophenols; Parkinson Disease; Population; Risk Factors; Single-Blind Method; Tolcapone

2000
Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Jan-15, Volume: 24, Issue:1

    Topics: Aged; Antiparkinson Agents; Benserazide; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Quality of Life; Severity of Illness Index; Treatment Outcome

2009
Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility--an open-label, 6-week study.
    Journal of neural transmission (Vienna, Austria : 1996), 2010, Volume: 117, Issue:3

    Topics: Aged; Antiparkinson Agents; Benserazide; Carbidopa; Catechols; Drug-Related Side Effects and Adverse Reactions; Dyskinesias; Feasibility Studies; Female; Humans; Levodopa; Male; Nitriles; Parkinson Disease; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome

2010
Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
    Clinical neuropharmacology, 2010, Volume: 33, Issue:3

    Topics: Age of Onset; Aged; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Drug Combinations; Drug Therapy, Combination; Dyskinesias; Enzyme Inhibitors; Female; Half-Life; Humans; Levodopa; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Nitrophenols; Parkinson Disease; Severity of Illness Index; Tolcapone; Tyrosine

2010
Replacing a dopamine agonist by the COMT-inhibitor tolcapone as an adjunct to L-dopa in the treatment of Parkinson's disease: a randomized, multicenter, open-label, parallel-group study.
    Clinical neuropharmacology, 2010, Volume: 33, Issue:3

    Topics: Aged; Ambulatory Care Facilities; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Dyskinesias; Enzyme Inhibitors; Feasibility Studies; Female; Humans; Levodopa; Male; Middle Aged; Nitrophenols; Parkinson Disease; Severity of Illness Index; Time Factors; Tolcapone; Treatment Outcome

2010
A double-blind, randomized, placebo and active-controlled study of nebicapone for the treatment of motor fluctuations in Parkinson's disease.
    CNS neuroscience & therapeutics, 2010, Volume: 16, Issue:6

    Topics: Acetophenones; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benserazide; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Double-Blind Method; Endpoint Determination; Enzyme Inhibitors; Female; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Treatment Outcome

2010
Effect of opicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity and motor fluctuations in patients with Parkinson's disease.
    European journal of neurology, 2015, Volume: 22, Issue:5

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benserazide; Carbidopa; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Oxadiazoles; Parkinson Disease; Treatment Outcome

2015
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson's disease patients with wearing-off.
    Journal of neural transmission (Vienna, Austria : 1996), 2015, Volume: 122, Issue:12

    Topics: Antiparkinson Agents; Benserazide; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Data Interpretation, Statistical; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Retrospective Studies; Treatment Outcome

2015
Effect of 3 Single-Dose Regimens of Opicapone on Levodopa Pharmacokinetics, Catechol-O-Methyltransferase Activity and Motor Response in Patients With Parkinson Disease.
    Clinical pharmacology in drug development, 2016, Volume: 5, Issue:3

    Topics: Adult; Aged; Antiparkinson Agents; Benserazide; Carbidopa; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Drug Interactions; Female; Humans; Levodopa; Male; Middle Aged; Oxadiazoles; Parkinson Disease

2016
Effect of opicapone multiple-dose regimens on levodopa pharmacokinetics.
    British journal of clinical pharmacology, 2017, Volume: 83, Issue:3

    Topics: Adult; Antiparkinson Agents; Benserazide; Biological Availability; Carbidopa; Catechol O-Methyltransferase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Oxadiazoles

2017

Other Studies

112 other study(ies) available for carbidopa and benserazide

ArticleYear
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
[Therapy of Parkinson's disease. Practical criteria of treatment].
    Recenti progressi in medicina, 1976, Volume: 60, Issue:5

    Topics: Amantadine; Antiparkinson Agents; Benserazide; Carbidopa; Cyproheptadine; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Piribedil; Pizotyline; Propranolol

1976
Effects of levodopa and dopamine of plasma glucose concentration in mice.
    European journal of pharmacology, 1977, Feb-21, Volume: 41, Issue:4

    Topics: Animals; Apomorphine; Benserazide; Blood Glucose; Carbidopa; Cyproheptadine; Dopamine; Fatty Acids, Nonesterified; Fenclonine; Haloperidol; Insulin; Levodopa; Liver Glycogen; Male; Methysergide; Mice; Nialamide; Pargyline; Pimozide; Time Factors

1977
Serotonergic stimulation of pituitary-adrenal activity in the mouse.
    Neuroendocrinology, 1978, Volume: 26, Issue:5

    Topics: 5-Hydroxytryptophan; Animals; Atropine; Benserazide; Carbidopa; Carbolines; Corticosterone; Cyproheptadine; Female; Fenclonine; Indoles; Metergoline; Mice; Pargyline; Phenyl Ethers; Pituitary-Adrenal System; Propylamines; Quinolines; Quipazine; Spiperone; Tryptophan

1978
Site of action of methyldopa in lowering the blood pressure in man.
    Clinical and experimental pharmacology & physiology. Supplement, 1978, Volume: 4

    Topics: Benserazide; Binding Sites; Blood Pressure; Carbidopa; Depression, Chemical; Humans; Methyldopa

1978
Role of peripheral mechanisms in the behavioral effects of 5-hydroxytryptophan.
    Pharmacology, biochemistry, and behavior, 1978, Volume: 9, Issue:2

    Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Benserazide; Carbidopa; Male; Proglumide; Rats; Reinforcement Schedule

1978
Evidence for a central monoaminergic influence on urinary bladder control mechanism.
    Scandinavian journal of urology and nephrology, 1979, Volume: 13, Issue:3

    Topics: 5-Hydroxytryptophan; Animals; Benserazide; Brain; Carbidopa; Catecholamines; Dopamine; Levodopa; Male; Norepinephrine; Parasympathetic Nervous System; Pressure; Rats; Spiperone; Urinary Bladder; Urodynamics

1979
Inhibition of human and rat hepatic aminotransferase activity with L-3,4-dihydroxyphenylalanine by inhibitors of peripheral aromatic amino acid decarboxylase.
    Molecular pharmacology, 1979, Volume: 15, Issue:1

    Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Carbidopa; Female; In Vitro Techniques; Kinetics; Levodopa; Liver; Male; Rats; Transaminases

1979
Niacin depletion in Parkinsonian patients treated with L-dopa, benserazide and carbidopa.
    Clinical science (London, England : 1979), 1979, Volume: 56, Issue:1

    Topics: Adolescent; Adult; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Hydrazines; Levodopa; Male; Micrococcus; Middle Aged; Nicotinamidase; Nicotinic Acids; Parkinson Disease; Tryptophan

1979
Effects of the inhibition of aromatic aminoacids decarboxylase on prolactin secretion in humans.
    Bollettino della Societa italiana di biologia sperimentale, 1979, Feb-28, Volume: 55, Issue:4

    Topics: Adult; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Bromocriptine; Carbidopa; Dopamine; Female; Humans; Prolactin

1979
L-Dopa inhibits prolactin secretion in proestrous rats.
    Endocrinology, 1977, Volume: 101, Issue:2

    Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Carbidopa; Female; Levodopa; Pregnancy; Proestrus; Prolactin; Rats; Time Factors

1977
Comparative effectiveness of two extracerebral DOPA decarboxylase inhibitors in Parkinson disease.
    Neurology, 1978, Volume: 28, Issue:9 Pt 1

    Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Carbidopa; Dihydroxyphenylalanine; Female; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease

1978
Plasma O-methyldopa in levodopa-induced dyskinesias. A bioclinical investigation.
    Acta neurologica Scandinavica, 1977, Volume: 56, Issue:6

    Topics: Aged; Benserazide; Carbidopa; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Methyldopa; Middle Aged; Parkinson Disease

1977
Effects of levodopa alone and in combination with dopa-decarboxylase inhibitors on plasma renin activity in patients with Parkinson's disease.
    Journal of neurology, neurosurgery, and psychiatry, 1978, Volume: 41, Issue:10

    Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Carbidopa; Drug Therapy, Combination; Furosemide; Humans; Hypotension, Orthostatic; Levodopa; Middle Aged; Parkinson Disease; Posture; Renin

1978
[Effect of VB6 on L-DOPA decarboxylase activity in the organs of rats given peripheral L-DOPA decarboxylase inhibitors (author's transl)].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1978, Volume: 15, Issue:6

    Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Carbidopa; Dopa Decarboxylase; Hydrazines; Levodopa; Male; Pyridoxine; Rats

1978
[Therapy of Parkinson's syndrome].
    Deutsche medizinische Wochenschrift (1946), 1976, Mar-12, Volume: 101, Issue:11

    Topics: Amantadine; Benserazide; Carbidopa; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Reserpine; Stereotaxic Techniques

1976
[Variations of the therapeutic action (on-off phenomenon) in patients with Parkin].
    La Clinica terapeutica, 1977, Jan-31, Volume: 80, Issue:2

    Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Carbidopa; Humans; Levodopa; Parkinson Disease, Secondary

1977
Does O-methyl-dopa play a role in levodopa-induced dyskinesias?
    Acta neurologica Scandinavica, 1977, Volume: 56, Issue:1

    Topics: Adult; Aged; Benserazide; Carbidopa; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Methyldopa; Middle Aged; Parkinson Disease

1977
Ethanol, levodopa and inhibitors of extracerebral aromatic L-amino acid decarboxylase: a drug-drug interaction study.
    Proceedings of the Western Pharmacology Society, 1977, Volume: 20

    Topics: Alcohol Drinking; Amino Acids; Animals; Benserazide; Carbidopa; Carboxy-Lyases; Choice Behavior; Drug Interactions; Levodopa; Male; Rats; Time Factors

1977
Lethality of tyrosine in mice: its potentiation by decarboxylase inhibitors and reversal byascorbic acid.
    Naunyn-Schmiedeberg's archives of pharmacology, 1976, Volume: 293, Issue:1

    Topics: Animals; Ascorbic Acid; Benserazide; Brocresine; Carbidopa; Drug Synergism; Intestinal Absorption; Kidney; Lethal Dose 50; Liver; Male; Mice; Phenylpyruvic Acids; Tyrosine; Tyrosine Decarboxylase

1976
In vivo assessment of decarboxylase inhibition or potentiation: urinary dopamine and L-dopa output after L-dopa administration.
    Journal of neural transmission, 1976, Volume: 38, Issue:3-4

    Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Carbidopa; Dopamine; Drug Interactions; Humans; Hydrazines; Levodopa; Parkinson Disease; Pyridoxine; Rats

1976
A comparison of the effects of decarboxylase inhibitors on L-dopa-induced circling behavior and the conversion of dopa to dopamine in the brain.
    Life sciences, 1976, Sep-01, Volume: 19, Issue:5

    Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior, Animal; Benserazide; Brain; Brocresine; Carbidopa; Dopamine; Hydrazines; Levodopa; Male; Methyldopa; Rats; Time Factors

1976
[Combined treatment of Parkinsonism with L-dopa and peripheral dopa decarboxylase inhibitors--clinical course of 13 cases and levels of serum/dopa and dopamine].
    Rinsho shinkeigaku = Clinical neurology, 1976, Jul-01, Volume: 16, Issue:7

    Topics: Adult; Aged; Benserazide; Carbidopa; Dihydroxyphenylalanine; Dopamine; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease

1976
Reinstatement of vaginal cycles in aged female rats.
    The Journal of pharmacology and experimental therapeutics, 1976, Volume: 199, Issue:2

    Topics: Aging; Animals; Benserazide; Carbidopa; Dose-Response Relationship, Drug; Drug Interactions; Estrus; Female; Fusaric Acid; Hypophysectomy; Levodopa; Phenoxybenzamine; Pimozide; Pregnancy; Propranolol; Rats; Tyrosine; Vagina

1976
Editorial: Long-term assessment of levodopa therapy in Parkinson's disease.
    Canadian Medical Association journal, 1975, Jun-21, Volume: 112, Issue:12

    Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Carbidopa; Drug Evaluation; Humans; Levodopa; Parkinson Disease; Parkinson Disease, Postencephalitic

1975
The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine.
    The Journal of pharmacology and experimental therapeutics, 1975, Volume: 193, Issue:2

    Topics: Animals; Behavior, Animal; Benserazide; Brain; Brain Chemistry; Carbidopa; Carboxy-Lyases; Dopamine; Droxidopa; Female; Histocytochemistry; In Vitro Techniques; Male; Myocardium; Norepinephrine; Rats; Serine; Serotonin; Stereoisomerism

1975
The action of L-dopa in rats with the raphe nuclei lesions.
    Polish journal of pharmacology and pharmacy, 1975, Volume: 27, Issue:Suppl

    Topics: Animals; Benserazide; Body Temperature; Brain; Carbidopa; Electric Stimulation; Hydroxyindoleacetic Acid; Levodopa; Rats; Serotonin; Thalamic Nuclei; Time Factors

1975
Centrally mediated increased reflex vagal bradycardia after L-dopa in monoamine oxidase-inhibited anesthetized dogs.
    The Journal of pharmacology and experimental therapeutics, 1976, Volume: 196, Issue:2

    Topics: Animals; Atropine; Benserazide; Blood Pressure; Carbidopa; Dogs; Dopamine; Drug Interactions; Female; Levodopa; Male; Monoamine Oxidase Inhibitors; Norepinephrine; Phentolamine; Pressoreceptors; Propranolol; Vagus Nerve

1976
The clinical efficacy of single morning doses of levodopa methyl ester: dispersible Madopar and Sinemet plus in Parkinson disease.
    Clinical neuropharmacology, 1992, Volume: 15, Issue:6

    Topics: Benserazide; Carbidopa; Drug Combinations; Humans; Levodopa; Middle Aged; Parkinson Disease

1992
Juvenile parkinsonism: ventricular CSF biopterin levels and clinical features.
    Journal of the neurological sciences, 1992, Volume: 108, Issue:2

    Topics: Adult; Age Factors; Benserazide; Biomarkers; Biopterins; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Motor Neurons; Parkinson Disease

1992
Kinetic-dynamic relationship of oral levodopa: possible biphasic response after sequential doses in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1992, Volume: 7, Issue:3

    Topics: Adult; Benserazide; Carbidopa; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease; Reaction Time

1992
Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia.
    Journal of neurology, neurosurgery, and psychiatry, 1990, Volume: 53, Issue:3

    Topics: Aged; Antiparkinson Agents; Benserazide; Carbidopa; Carboxy-Lyases; Dose-Response Relationship, Drug; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Hydrazines; Levodopa; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease

1990
Treatment of early Parkinson's disease with controlled-release levodopa preparations.
    Neurology, 1989, Volume: 39, Issue:11 Suppl 2

    Topics: Aged; Antiparkinson Agents; Benserazide; Carbidopa; Delayed-Action Preparations; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Parkinson Disease

1989
Disability profiles and objective quantitative assessment in Parkinson's disease.
    Acta neurologica Scandinavica, 1989, Volume: 79, Issue:3

    Topics: Adult; Aged; Benserazide; Carbidopa; Disability Evaluation; Drug Combinations; Female; Humans; Levodopa; Locomotion; Male; Middle Aged; Parkinson Disease; Posture; Psychomotor Performance; Reaction Time

1989
[The problems of L-dopa therapy in the course of Parkinson syndrome].
    Fortschritte der Neurologie-Psychiatrie, 1989, Volume: 57, Issue:5

    Topics: Adult; Aged; Benserazide; Carbidopa; Disability Evaluation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies

1989
Painful Parkinson's disease.
    Lancet (London, England), 1986, Jun-14, Volume: 1, Issue:8494

    Topics: Acute Disease; Adult; Aged; Antiparkinson Agents; Benserazide; Carbidopa; Drug Administration Schedule; Drug Combinations; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Pain; Parkinson Disease; Time Factors

1986
Diuretic effect of L-threo-3,4-dihydroxyphenylserine, a noradrenaline precursor, in rats and mice.
    The Journal of pharmacy and pharmacology, 1986, Volume: 38, Issue:7

    Topics: Animals; Benserazide; Carbidopa; Diuretics; Dose-Response Relationship, Drug; Droxidopa; Drug Interactions; Male; Mice; Norepinephrine; Rats; Rats, Inbred Strains; Serine; Species Specificity

1986
[Therapeutic strategies and tactics in parkinsonism].
    Wiener medizinische Wochenschrift (1946), 1986, Aug-31, Volume: 136, Issue:15-16

    Topics: Amantadine; Antidepressive Agents; Antiparkinson Agents; Benserazide; Carbidopa; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Motor Skills; Parkinson Disease; Selegiline; Sleep Initiation and Maintenance Disorders

1986
Effects of 5-hydroxytryptamine, dopamine, and aromatic L-amino acids on growth hormone (GH)-releasing factor-stimulated GH release in rat anterior pituitaries.
    Endocrinology, 1987, Volume: 120, Issue:2

    Topics: Animals; Benserazide; Carbidopa; Dopamine; Growth Hormone; Growth Hormone-Releasing Hormone; In Vitro Techniques; Kinetics; Levodopa; Male; Pituitary Gland, Anterior; Rats; Rats, Inbred Strains; Serotonin; Tyrosine

1987
Current and future approaches to therapy.
    Advances in neurology, 1987, Volume: 45

    Topics: Antiparkinson Agents; Benserazide; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Selegiline

1987
Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
    European neurology, 1987, Volume: 27 Suppl 1

    Topics: Administration, Oral; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Brain; Carbidopa; Delayed-Action Preparations; Dihydroxyphenylalanine; Dogs; Dopa Decarboxylase; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hydrazines; Kidney; Levodopa; Liver; Male; Mice; Rats; Time Factors; Tyrosine

1987
Parkinson's disease.
    Comprehensive therapy, 1986, Volume: 12, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amantadine; Animals; Benserazide; Carbidopa; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Rats

1986
Management of Parkinson's disease in general practice.
    Scottish medical journal, 1986, Volume: 31, Issue:2

    Topics: Aged; Benserazide; Bromocriptine; Carbidopa; Drug Combinations; Family Practice; Humans; Levodopa; Medical Audit; Parkinson Disease

1986
Comparison of levodopa with carbidopa, and levodopa with domperidone in Parkinson's disease.
    Clinical neuropharmacology, 1986, Volume: 9, Issue:5

    Topics: Adult; Aged; Benserazide; Carbidopa; Domperidone; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1986
[L-dopa therapy of parkinson syndrome].
    Der Nervenarzt, 1985, Volume: 56, Issue:2

    Topics: Benserazide; Biotransformation; Carbidopa; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Long-Term Care; Parkinson Disease; Receptors, Dopamine

1985
Deprenyl in Parkinson disease: personal experience.
    Italian journal of neurological sciences, 1985, Volume: 6, Issue:2

    Topics: Adult; Aged; Benserazide; Carbidopa; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Phenethylamines; Selegiline

1985
Autonomic cardiovascular responses in parkinsonism: effect of levodopa with dopa-decarboxylase inhibition.
    Acta neurologica Scandinavica, 1985, Volume: 71, Issue:1

    Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Autonomic Nervous System; Benserazide; Blood Pressure; Carbidopa; Drug Therapy, Combination; Female; Heart; Heart Rate; Humans; Hydrazines; Levodopa; Male; Middle Aged; Muscle Contraction; Parkinson Disease

1985
Inhibitory effect of drugs used in the treatment of Parkinson's disease on plasma monoamine oxidase activity.
    Journal of neural transmission, 1985, Volume: 61, Issue:3-4

    Topics: Adult; Aged; Benserazide; Benzylamine Oxidase; Carbidopa; Female; Humans; Hydrazines; Isoenzymes; Male; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease

1985
Genetic toxicity of several antihypertensive drugs possessing a hydrazine group.
    Research communications in chemical pathology and pharmacology, 1985, Volume: 49, Issue:3

    Topics: Animals; Antihypertensive Agents; Benserazide; Carbidopa; Hydralazine; Hydrazines; Male; Mutagens; Rats; Rats, Inbred ACI

1985
[Drug therapy of Parkinson's disease].
    Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1985, Volume: 18, Issue:4

    Topics: Adult; Aged; Antiparkinson Agents; Benserazide; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1985
[Clinical significance of cramps of the lower extremities in patients with parkinsonism].
    Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1985, Volume: 18, Issue:4

    Topics: Aged; Antiparkinson Agents; Benserazide; Carbidopa; Drug Combinations; Female; Humans; Hydrazines; Leg; Levodopa; Male; Middle Aged; Muscle Cramp; Parkinson Disease

1985
Blood-brain barrier to carbidopa (MK-486) and Ro 4-4602, peripheral dopa decarboxylase inhibitors.
    The Journal of pharmacy and pharmacology, 1973, Volume: 25, Issue:5

    Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Blood-Brain Barrier; Carbidopa; Carbon Isotopes; Chromatography, Paper; Hydrazines; Oils; Permeability; Tritium; Water

1973
Aterial blood pressure in dogs: effects of m-tyrosine alone or in combination with inhibitors of aromatic amino acid decarboxylase; relative hypotensive potencies of L-dopa, DL-m-tyrosine, and L-m-tyrosine.
    Experientia, 1974, Sep-15, Volume: 30, Issue:9

    Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Blood Pressure; Carbidopa; Dihydroxyphenylalanine; Dogs; Female; Heart Rate; Hydrazines; Male; Tyrosine

1974
[Decarboxylase inhibitors combined with L-dopa in the treatment of Parkinson's disease].
    La Revue du praticien, 1974, Mar-11, Volume: 24, Issue:15

    Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Benzyl Compounds; Carbidopa; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Parkinson Disease; Phenols

1974
The effects of L-dopa and alpha-methyldopa on reflexes and sympathetic nerve function.
    European journal of pharmacology, 1974, Volume: 25, Issue:1

    Topics: Animals; Atropine; Barbiturates; Benserazide; Blood Pressure; Carbidopa; Carotid Arteries; Dogs; Electric Stimulation; Heart Rate; Hindlimb; Levodopa; Methyldopa; Monoamine Oxidase Inhibitors; Neurons; Perfusion; Posture; Reflex; Regional Blood Flow; Sympathetic Nervous System; Vagotomy; Vagus Nerve

1974
L-DOPA: centrally mediated emission of seminal fluid in male rats.
    Life sciences. Pt. 1: Physiology and pharmacology, 1972, May-01, Volume: 11, Issue:9

    Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Atropine; Benserazide; Carbidopa; Cyproheptadine; Dihydroxyphenylalanine; Dopamine; Ejaculation; Haloperidol; Hydrazines; Hypophysectomy; Lysergic Acid Diethylamide; Male; Melatonin; Methysergide; Norepinephrine; Phentolamine; Propranolol; Rats; Semen; Serotonin

1972
Dopa decarboxylase from visceral ganglion and gill of two lamellibranch mollusca as it relates to ciliary activity.
    Comparative and general pharmacology, 1973, Volume: 4, Issue:16

    Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Carbidopa; Carbon Radioisotopes; Carboxy-Lyases; Cilia; Dopa Decarboxylase; Electric Stimulation; Ganglia; Gills; In Vitro Techniques; Methyldopa; Mollusca; Serotonin; Time Factors; Tritium

1973
Central action of L-DOPA in blood pressure regulation and effect on catecholamine content in the frog, Xenopus laevis.
    Comparative biochemistry and physiology. C: Comparative pharmacology, 1981, Volume: 70, Issue:1

    Topics: Animals; Benserazide; Blood Pressure; Brain; Carbidopa; Catecholamines; Dopamine; Female; Levodopa; Myocardium; Xenopus laevis

1981
The effect of L-DOPA on blood pressure and catecholamine content in the brain and peripheral organs in the Atlantic cod, Gadus morhua.
    Comparative biochemistry and physiology. C: Comparative pharmacology, 1981, Volume: 70, Issue:2

    Topics: Animals; Benserazide; Blood Pressure; Brain Chemistry; Carbidopa; Catecholamines; Dopamine; Fishes; Levodopa; Time Factors

1981
Dopamine agonists in clinical research for new tardive dyskinesia treatments.
    Modern problems of pharmacopsychiatry, 1983, Volume: 21

    Topics: Adult; Aged; Antipsychotic Agents; Apomorphine; Benserazide; Carbidopa; Dopamine; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Hydrazines; Levodopa; Middle Aged; Synaptic Transmission

1983
DOPA decarboxylase activity in the nervous system and the ctenidium of the freshwater clam, Musculium (Sphaerium) transversum.
    Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology, 1984, Volume: 77, Issue:1

    Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Bivalvia; Carbidopa; Dopa Decarboxylase; Methyldopa; Nervous System; Respiratory System

1984
Human pharmacokinetics of long term 5-hydroxytryptophan combined with decarboxylase inhibitors.
    European journal of clinical pharmacology, 1982, Volume: 23, Issue:1

    Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Blood Platelets; Carbidopa; Drug Interactions; Female; Humans; Hydrazines; Hydroxyindoleacetic Acid; Kinetics; Male; Middle Aged; Protein Binding

1982
Effect of some serotoninergic agents on the rectal temperature of the domestic fowl (Gallus domesticus).
    Neuropharmacology, 1984, Volume: 23, Issue:12A

    Topics: 5-Hydroxytryptophan; Animals; Animals, Newborn; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Body Temperature; Body Temperature Regulation; Carbidopa; Cattle; Chickens; Citalopram; Cyproheptadine; Fenclonine; Lysergic Acid Diethylamide; Male; Methysergide; Propylamines; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Time Factors

1984
Evidence that the effects of 5-hydroxytryptophan on the secretion of ACTH and growth hormone in dogs are not mediated by central release of serotonin.
    Neuroendocrinology, 1982, Volume: 34, Issue:1

    Topics: 11-Hydroxycorticosteroids; 5-Hydroxytryptophan; Adrenocorticotropic Hormone; Animals; Benserazide; Carbidopa; Dogs; Female; Growth Hormone; Kinetics; Male; Metergoline; Serotonin

1982
Deprenyl (selegiline) in combination treatment of Parkinson's disease.
    Acta neurologica Scandinavica. Supplementum, 1983, Volume: 95

    Topics: Aged; Benserazide; Carbidopa; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Phenethylamines; Selegiline

1983
Effects of benserazide, carbidopa and isoniazid administration on tryptophan-nicotinamide nucleotide metabolism in the rat.
    Biochemical pharmacology, 1980, Aug-01, Volume: 29, Issue:15

    Topics: Animals; Benserazide; Body Weight; Carbidopa; Diet; Hydrazines; Isoniazid; Liver; Male; Niacinamide; Rats; Ribonucleotides; Time Factors; Tryptophan

1980
Combined use of benserazide and carbidopa in Parkinson's disease.
    Neurology, 1984, Volume: 34, Issue:2

    Topics: Adult; Aged; Benserazide; Carbidopa; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Outcome and Process Assessment, Health Care; Parkinson Disease

1984
Dystonia--L-dopa responsive or juvenile parkinsonism?
    Journal of neural transmission. Supplementum, 1983, Volume: 19

    Topics: Adolescent; Benserazide; Carbidopa; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dystonia; Follow-Up Studies; Growth Hormone; Humans; Infant; Levodopa; Male; Parkinson Disease; Prolactin

1983
Response to Sinemet 25/100 in Parkinson's disease.
    Advances in neurology, 1984, Volume: 40

    Topics: Aged; Benserazide; Body Weight; Carbidopa; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Sex Factors

1984
[Treatment of patients with vascular parkinsonism with the preparations nakom and madopar].
    Klinicheskaia meditsina, 1984, Volume: 62, Issue:4

    Topics: Adult; Aged; Antiparkinson Agents; Benserazide; Carbidopa; Drug Combinations; Humans; Hydrazines; Levodopa; Middle Aged; Parkinson Disease, Secondary

1984
Presynaptic neuron and postsynaptic dopamine receptor function in long term treatment of Parkinson's disease: a neuroendocrine study.
    Progress in clinical and biological research, 1980, Volume: 39

    Topics: Aged; Apomorphine; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Nomifensine; Parkinson Disease; Prolactin; Receptors, Dopamine; Selegiline; Tremor

1980
Effect of levodopa on thyroid function and prolactin release. A study in patients with Parkinson's disease.
    Archives of neurology, 1981, Volume: 38, Issue:12

    Topics: Aged; Benserazide; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prolactin; Thyroid Gland; Thyrotropin; Thyrotropin-Releasing Hormone

1981
The effect of carbidopa and benserazide on human plasma 5-hydroxytryptophan levels.
    Journal of neural transmission, 1982, Volume: 53, Issue:1

    Topics: 5-Hydroxytryptophan; Adult; Benserazide; Carbidopa; Chlorpromazine; Dihydroxyphenylalanine; Humans; Hydrazines; Middle Aged; Parkinson Disease; Schizophrenia; Tryptophan

1982
Thyrotrophin and prolactin responses to thyrotrophin-releasing hormone in patients with Parkinson's disease.
    Acta endocrinologica, 1982, Volume: 99, Issue:3

    Topics: Adult; Aged; Antiparkinson Agents; Benserazide; Carbidopa; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine

1982
The effect of some decarboxylase inhibitors on striatal tyramines in the mouse.
    Neuropharmacology, 1983, Volume: 22, Issue:1

    Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Carbidopa; Carboxy-Lyases; Corpus Striatum; Hydrazines; Isomerism; Male; Mice; Tyramine

1983
Evidence for a peripheral effect of sertonin or metabolites in 5-hydroxytryptophan-induced hypothermia.
    Neuropharmacology, 1980, Volume: 19, Issue:8

    Topics: 5-Hydroxytryptophan; Amidines; Animals; Benserazide; Body Temperature; Carbidopa; Dose-Response Relationship, Drug; Male; Phenyl Ethers; Rats; Serotonin; Temperature; Time Factors

1980
Peripheral conversion of L-5-hydroxytryptophan to serotonin induces drinking in rats.
    Pharmacology, biochemistry, and behavior, 1981, Volume: 14, Issue:6

    Topics: 5-Hydroxytryptophan; Animals; Benserazide; Carbidopa; Dose-Response Relationship, Drug; Drinking Behavior; Female; Methysergide; Rats; Receptors, Serotonin; Serotonin

1981
Pharmacological evidence that stimulation of central serotonergic pathways increases renin secretion.
    Neuroendocrinology, 1980, Volume: 30, Issue:2

    Topics: 5-Hydroxytryptophan; Animals; Benserazide; Carbidopa; Denervation; Dogs; Female; Kidney; Male; Metergoline; Renin; Serotonin; Tryptophan

1980
Prolactin response to acute administration of different L-dopa plus decarboxylase inhibitors in Parkinson's disease.
    Neuropsychobiology, 1982, Volume: 8, Issue:2

    Topics: Aged; Animals; Benserazide; Carbidopa; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Prolactin; Rats

1982
The effect of L-dopa on pupillary diameter in mice.
    Experientia, 1982, Apr-15, Volume: 38, Issue:4

    Topics: Animals; Benserazide; Carbidopa; Fusaric Acid; Levodopa; Male; Mice; Mice, Inbred ICR; Phentolamine; Pupil

1982
Parkinsonism in the elderly.
    Current medical research and opinion, 1982, Volume: 7, Issue:Suppl 1

    Topics: Aged; Antiparkinson Agents; Benserazide; Carbidopa; Humans; Levodopa; Parkinson Disease

1982
Central cardiovascular effects of L-DOPA and clonidine in the lizard, Agama caudospinosa.
    Acta physiologica Scandinavica, 1982, Volume: 116, Issue:1

    Topics: Animals; Benserazide; Blood Pressure; Blood-Brain Barrier; Brain; Carbidopa; Catecholamines; Clonidine; Heart Rate; Hemodynamics; Levodopa; Lizards; Myocardium

1982
New strategies in the management of Parkinson's disease: a biological approach using a phospholipid precursor (CDP-choline).
    Neuropsychobiology, 1982, Volume: 8, Issue:6

    Topics: Adult; Aged; Benserazide; Carbidopa; Choline; Cytidine Diphosphate Choline; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine

1982
Comparative 90-day toxicity of two decarboxylase inhibitors, benserazide and carbidopa, in the rat.
    Toxicology and applied pharmacology, 1982, Volume: 66, Issue:2

    Topics: Animals; Benserazide; Blood; Bone and Bones; Carbidopa; Carboxy-Lyases; Dose-Response Relationship, Drug; Eating; Female; Growth Disorders; Hydrazines; Male; Organ Size; Radiography; Rats; Rats, Inbred Strains

1982
Systemic and in vitro effects of GAD and GABA-T inhibitors on AADC activity and of AADC inhibitors on GAD.
    General pharmacology, 1981, Volume: 12, Issue:4

    Topics: 4-Aminobutyrate Transaminase; Adrenal Glands; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Benzyl Alcohols; Carbidopa; Carboxy-Lyases; Corpus Striatum; Female; Glutamate Decarboxylase; Hydrazines; Penicillamine; Rats; Transaminases

1981
Effects of benserazide and carbidopa on the metabolism of L-tryptophan by isolated rat liver cells.
    Biochemical pharmacology, 1981, Mar-15, Volume: 30, Issue:6

    Topics: Alanine; Animals; Benserazide; Carbidopa; Chemical Phenomena; Chemistry; Hydrazines; Hydrolases; Liver; Oxidation-Reduction; Pyruvates; Rats; Tryptophan; Tryptophan Oxygenase

1981
Dose and sex related effects of aromatic aminoacids decarboxylase inhibitors on serum prolactin in humans.
    Acta endocrinologica, 1980, Volume: 93, Issue:1

    Topics: Administration, Oral; Adult; Age Factors; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Carbidopa; Dose-Response Relationship, Drug; Female; Humans; Hydrazines; Male; Prolactin; Sex Factors

1980
Benserazide and carbidopa as substrates of catechol-O-methyltransferase: new mechanism of action in Parkinson's disease.
    Biochemical pharmacology, 1980, Dec-01, Volume: 29, Issue:23

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benserazide; Benzyl Compounds; Carbidopa; Catechol O-Methyltransferase; Hydrazines; Kinetics; Liver; Parkinson Disease; S-Adenosylmethionine; Substrate Specificity; Swine

1980
Contrasting effects of peripheral decarboxylase inhibitors on plasma activity of aromatic-L-amino acid decarboxylase and semicarbazide-sensitive amine oxidase in Parkinson's disease.
    Life sciences, 1995, Volume: 57, Issue:19

    Topics: Aged; Amine Oxidase (Copper-Containing); Antiparkinson Agents; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Carbidopa; Cross-Sectional Studies; Dialysis; Drug Synergism; Enzyme Inhibitors; Female; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease

1995
Dopa-unresponsive pure akinesia or freezing. A condition within a wide spectrum of PSP?
    Advances in neurology, 1993, Volume: 60

    Topics: Benserazide; Carbidopa; Diagnosis, Differential; Drug Therapy, Combination; Humans; Levodopa; Motor Activity; Movement Disorders; Neurologic Examination; Ocular Motility Disorders; Parkinson Disease; Parkinson Disease, Secondary; Supranuclear Palsy, Progressive

1993
Potent COMT inhibition by Ro 40-7592 in the periphery and in the brain. Preclinical and clinical findings.
    Advances in neurology, 1993, Volume: 60

    Topics: Animals; Benserazide; Benzophenones; Brain; Carbidopa; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Dose-Response Relationship, Drug; Erythrocytes; Homovanillic Acid; Humans; Levodopa; Male; Nitrophenols; Peripheral Nerves; Rats; S-Adenosylhomocysteine; S-Adenosylmethionine; Tolcapone

1993
Nocturnal akathisia in Parkinson's disease: treatment with clozapine.
    Movement disorders : official journal of the Movement Disorder Society, 1993, Volume: 8, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Benserazide; Carbidopa; Circadian Rhythm; Clozapine; Confusion; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Psychomotor Agitation; Sleep Wake Disorders

1993
Locally formed dopamine modulates renal Na-Pi co-transport through DA1 and DA2 receptors.
    The Biochemical journal, 1995, Dec-01, Volume: 312 ( Pt 2)

    Topics: Adenylate Cyclase Toxin; Animals; Benserazide; Bromocriptine; Calcium; Carbidopa; Carrier Proteins; Cell Line; Cyclic AMP; Dopamine; Kidney Tubules, Proximal; Kinetics; Levodopa; Opossums; Parathyroid Hormone; Pertussis Toxin; Phosphates; Receptors, Dopamine D1; Receptors, Dopamine D2; Sodium; Sodium-Phosphate Cotransporter Proteins; Symporters; Virulence Factors, Bordetella

1995
In vivo microdialysis to determine the relative pharmacokinetics of drugs.
    Biological & pharmaceutical bulletin, 1996, Volume: 19, Issue:7

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Benserazide; Brain Chemistry; Carbidopa; Chromatography, High Pressure Liquid; Dopamine; Drug Interactions; Electrochemistry; Homovanillic Acid; Levodopa; Male; Methoxyhydroxyphenylglycol; Microdialysis; Neostriatum; Rats; Rats, Wistar

1996
Clinical implications of sustained dopaminergic stimulation.
    Clinical neuropharmacology, 1994, Volume: 17 Suppl 2

    Topics: Aged; Benserazide; Carbidopa; Delayed-Action Preparations; Dopamine Agonists; Drug Combinations; Dyskinesia, Drug-Induced; Follow-Up Studies; Humans; Levodopa; Lisuride; Parkinson Disease; Reaction Time

1994
Highlights of the North American and European experiences.
    Neurology, 1998, Volume: 50, Issue:5 Suppl 5

    Topics: Antiparkinson Agents; Benserazide; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Dopamine Agents; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Enzyme Inhibitors; Europe; Humans; Levodopa; Nitrophenols; North America; Parkinson Disease; Randomized Controlled Trials as Topic; Tolcapone

1998
The reach-to-grasp movement in Parkinson's disease before and after dopaminergic medication.
    Neuropsychologia, 2000, Volume: 38, Issue:1

    Topics: Adult; Aged; Antiparkinson Agents; Basal Ganglia; Benserazide; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Psychomotor Performance; Reaction Time; Receptors, Dopamine

2000
Quality control of benserazide-levodopa and carbidopa-levodopa tablets by capillary zone electrophoresis.
    Electrophoresis, 2000, Volume: 21, Issue:12

    Topics: Benserazide; Carbidopa; Electrophoresis, Capillary; Levodopa; Molecular Structure; Quality Control

2000
Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat.
    Journal of neural transmission (Vienna, Austria : 1996), 2001, Volume: 108, Issue:5

    Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Carbidopa; Decarboxylation; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Extracellular Space; Levodopa; Male; Microdialysis; Neostriatum; Parkinson Disease; Rats; Rats, Wistar

2001
Structural insight into Parkinson's disease treatment from drug-inhibited DOPA decarboxylase.
    Nature structural biology, 2001, Volume: 8, Issue:11

    Topics: 5-Hydroxytryptophan; Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Binding Sites; Carbidopa; Crystallography, X-Ray; Dopa Decarboxylase; Drug Design; Humans; Kidney; Levodopa; Ligands; Models, Molecular; Parkinson Disease; Pliability; Protein Structure, Secondary; Swine

2001
[Benefit of L-DOPA-without-DCI (decarboxylase inhibitor) therapy on wearing-off phenomenon in advanced stages of Parkinson's disease patients].
    No to shinkei = Brain and nerve, 2002, Volume: 54, Issue:2

    Topics: Adult; Aged; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Carbidopa; Circadian Rhythm; Drug Tolerance; Enzyme Inhibitors; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Severity of Illness Index; Treatment Outcome

2002
Binding site of salsolinol: its properties in different regions of the brain and the pituitary gland of the rat.
    Neurochemistry international, 2003, Volume: 42, Issue:1

    Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Binding Sites; Binding, Competitive; Brain; Carbidopa; Clonidine; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Enzyme Inhibitors; Female; Isoquinolines; Kinetics; Lactation; Levodopa; Male; Mazindol; Median Eminence; Methyldopa; Pituitary Gland; Pituitary Gland, Posterior; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Reserpine

2003
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy.
    Journal of neurology, 2009, Volume: 256, Issue:3

    Topics: Aged; Aged, 80 and over; Benserazide; Benzothiazoles; Brain; Carbidopa; Dopamine Agents; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Time Factors; Tomography, Emission-Computed, Single-Photon; Tropanes

2009
Kinetic characterization of the oxidation of carbidopa and benserazide by tyrosinase and peroxidase.
    Bioscience, biotechnology, and biochemistry, 2009, Volume: 73, Issue:6

    Topics: Benserazide; Carbidopa; Kinetics; Monophenol Monooxygenase; Oxidation-Reduction; Peroxidases; Spectrophotometry, Ultraviolet

2009
Inhibition in vitro of the enzymes of the oxidative pathway of tryptophan metabolism and of nicotinamide nucleotide synthesis by benserazide, carbidopa and isoniazid.
    Biochemical pharmacology, 1980, Mar-01, Volume: 29, Issue:5

    Topics: Animals; Benserazide; Carbidopa; Isoniazid; Male; Niacinamide; Nucleotides; Oxidation-Reduction; Rats; Rats, Wistar; Tryptophan

1980
The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset.
    European journal of pharmacology, 2010, Jun-10, Volume: 635, Issue:1-3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Callithrix; Carbidopa; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Enzyme Inhibitors; Female; Levodopa; Male; Methyldopa; Motor Activity; Movement Disorders

2010
Simultaneous voltammetric determination of levodopa, carbidopa and benserazide in pharmaceuticals using multivariate calibration.
    Talanta, 2010, Aug-15, Volume: 82, Issue:3

    Topics: Algorithms; Benserazide; Calibration; Carbidopa; Dopamine Agents; Drug Combinations; Electrochemical Techniques; Electrodes; Excipients; Levodopa

2010
Executive control in Parkinson's disease: effects of dopaminergic medication and deep brain stimulation on anti-cue keypress performance.
    Neuroscience letters, 2011, Aug-15, Volume: 500, Issue:2

    Topics: Aged; Benserazide; Benzothiazoles; Carbidopa; Cues; Deep Brain Stimulation; Dopamine Agents; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Psychomotor Performance; Reaction Time; Subthalamic Nucleus

2011
Relationship between 3-O-methyldopa and the clinical effects of entacapone in advanced Parkinson's disease.
    Hiroshima journal of medical sciences, 2011, Volume: 60, Issue:3

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Biomarkers; Carbidopa; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catechols; Disease Progression; Dopa Decarboxylase; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Japan; Levodopa; Male; Middle Aged; Motor Activity; Nitriles; Parkinson Disease; Prospective Studies; Treatment Outcome; Tyrosine

2011
Development and Validation of a Robust and Efficient HPLC Method for the Simultaneous Quantification of Levodopa, Carbidopa, Benserazide and Entacapone in Complex Matrices.
    Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2017, Volume: 20, Issue:0

    Topics: Antiparkinson Agents; Benserazide; Carbidopa; Catechols; Chromatography, High Pressure Liquid; Levodopa; Molecular Structure; Nitriles

2017
Levodopa/dopa decarboxylase inhibitor associated microscopic colitis: An under-recognized drug reaction.
    Parkinsonism & related disorders, 2021, Volume: 86

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benserazide; Carbidopa; Cohort Studies; Colitis, Microscopic; Drug Combinations; Enzyme Inhibitors; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies

2021
The relationship between the distinct ratios of benserazide and carbidopa to levodopa and motor complications in Parkinson's disease: A retrospective cohort study.
    Journal of the neurological sciences, 2022, 06-15, Volume: 437

    Topics: Antiparkinson Agents; Benserazide; Carbidopa; Drug Combinations; Humans; Levodopa; Parkinson Disease; Retrospective Studies

2022